# SuperBAC Bio Technology Solutions

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/superbac-bio-technology-solutions

- Industry: Biotechnology
- Headquarters: Sao Paulo, Brazil
- Website: www.superbac.com.br
- Latest round: Series A (Jan 1, 2007)
- Investors on record: 1

## About

SuperBAC Bio Technology Solutions specializes in biotechnological products aimed at enhancing agricultural productivity and sustainability through innovative solutions.Founded in 1995, SuperBAC Bio Technology Solutions is based in Sao Paulo, Brazil, and focuses on developing biotechnological solutions for agriculture. The company has participated in 5 significant deals, with the most recent funding round occurring on June 5, 2023, which was a Secondary Buyout totaling BRL 300 million from XP Asset Management. The total amount raised by the company is BRL 300 million. Luiz Filho is the CEO, leading the company towards its strategic growth initiatives.SuperBAC specializes in biotechnological solutions aimed at enhancing agricultural productivity and sustainability. The company offers a range of products, including their flagship biofertilizers, which incorporate SMARTBAC technology to promote beneficial microbial activity in the soil. These products are designed to improve soil characteristics, leading to healthier plant growth and increased crop yields. Additionally, SuperBAC provides soil analysis services and microbiome assessments using advanced methodologies like molecular biology and DNA sequencing. Their primary markets include agriculture, pharmaceuticals, and cosmetics, with a focus on Brazil and potential expansion into other Latin American countries.In the most recent fiscal year of 2022, SuperBAC generated revenue amounting to BRL 201,964,832.70, with an EBITDA of BRL 8,406,566.20.SuperBAC Bio Technology Solutions plans to leverage its recent investment of BRL 300 million from XP Private Equity, which acquired a 30% minority stake, to advance its biotechnology sector operations both in Brazil and internationally. The funds will support the development of new biotechnological products aimed at enhancing agricultural outputs, as well as expanding into new geographic markets by 2024.

## Funding rounds

- Series A, Jan 1, 2007 — Armilar Venture Partners

## Investors

- Armilar Venture Partners (https://capitalatlas.ai/funds/armilar-venture-partners) — Series A
